Cirius Therapeutics nets $40 mln

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on treating liver diseases, has closed its Series A financing round at $40 million. Frazier Healthcare Partners and Novo A/S led the round. Also, Cirius has appointed Bob Baltera as CEO, Dr. Howard Dittrich as chief medical officer and Brian Farmer as chief business officer. And, the company will open an office in San Diego while retaining its R&D operations in Kalamazoo, Michigan.

North AmericaUSBriefs